The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Celiac Plexus Radiosurgery for Pain Management
Official Title: Celiac Plexus Radiosurgery for Pain Management in Advanced Cancer Patients - a Phase II Trial
Study ID: NCT02356406
Brief Summary: This prospective study evaluates celiac plexus radiosurgery for pain control in patients with upper abdominal malignancies.
Detailed Description: This study aims as primary objective to evaluate short and long term pain relief following the administration of radiosurgery to the celiac plexus in patients with upper abdominal cancer. As secondary objectives it will describe acute and late side effects and quality of life measures of patients undergoing the treatment. The study has a prospective, single arm design. It will be composed from an initial run-in safety assessment that will include 6 patients and then continue as a phase II trial. All eligible patients will receive the same protocol of celiac plexus radiosurgery and will be evaluated before, during and following this treatment. The treatment duration is one and a half weeks (5 fractions delivered every other weekday).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Sheba Medical Center, Ramat-Gan, , Israel
Name: David Hausner, M.D
Affiliation: Sheba Medical Center
Role: PRINCIPAL_INVESTIGATOR